AKT1 and prostate cancer: Berrak et al. [65] inhibited the PI3K/AKT/mTOR pathway to test the relationship between autophagy and apoptosis in the prostate cancer cells, and some researchers [66] inhibited the NO pathway to detect the proliferation ability of endothelial cells.